Breaking the Burden: A New Way to Deliver Anti-VEGF.

Research output: Contribution to specialist publicationArticle

Abstract

The article discusses the evolution of anti-vascular endothelial growth factor (VEGF) therapy in treating patient with age-related macular degeneration (AMD), retinal vein occlusions and diabetic macular edema. Topics mention including challenges in bringing the efficacy which are demonstrated in clinical trials, development of Port Delivery System (PDS) by Roche and targeting of platelet-derived growth factor (PDGF).
Original languageEnglish
Pages60-63
Number of pages4
Volume155
No2
Specialist publicationReview of Optometry
PublisherJobson Healthcare Information LLC
StatePublished - 15 Feb 2018

Keywords

  • RETINAL degeneration treatment
  • VASCULAR endothelial growth factors
  • EYE diseases
  • RETINAL vein occlusion
  • PLATELET-derived growth factor
  • THERAPEUTICS

Fingerprint

Dive into the research topics of 'Breaking the Burden: A New Way to Deliver Anti-VEGF.'. Together they form a unique fingerprint.

Cite this